Online inquiry

IVTScrip™ mRNA-Human ADAMTS1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK14298MR)

This product GTTS-WK14298MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADAMTS1 protein. This product can be used in FGFR1 High NME5-epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_006988.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 9510
UniProt ID Q9UHI8
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADAMTS1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK14298MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK28244MR IVTScrip™ mRNA-Human APPL2, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA APPL2
GTTS-WK23105MR IVTScrip™ mRNA-Human Apelin, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA Apelin
GTTS-WK25055MR IVTScrip™ mRNA-Human ARMC4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARMC4
GTTS-WK25063MR IVTScrip™ mRNA-Human ARNTL, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARNTL
GTTS-WK24996MR IVTScrip™ mRNA-Human ARHGAP32, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP32
GTTS-WK24069MR IVTScrip™ mRNA-Human ARFGAP1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARFGAP1
GTTS-WK21504MR IVTScrip™ mRNA-Human ANKRD18A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD18A
GTTS-WK28397MR IVTScrip™ mRNA-Human ASB16-AS1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ASB16-AS1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW